[Effects of icariin on the proliferation, differentiation and maturation of rat calvarial osteoblasts in vitro]. 2011

Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
College of Life Science and Engineering, Lanzhou University of Technology, Lanzhou 730050, China. zhaiyk1984@163.com

OBJECTIVE To investigate the effects of icariin on the proliferation, differentiation and maturation of rat calvarial osteoblasts (ROB). METHODS Segregated neonatal SD rat skull,enzyme digestion to obtain ROB. The culture medium was replaced every three days. Serial subcultivation proceeded when cells covered with 80% culture dish. Icariin was added into the culture at 1 x 10(-4), 1 x 10(-5), 1 x 10(-6), 1 x 10(-7) mol/L respectively. MTT method was adopted in proliferation analysis. The activity of ALP was assayed after 9 days' induced. Optimal concentration icariin was added into the medium, then the osteogenic differentiation markers including mineralized bone nodules, CFU-F(ALP) were compared between the icariin-added group and the control. Total RNA was isolated and the gene expressions of Runx-2 and Osterix were investigated by Real Time RT-PCR. Total protein was also isolated and the secretion of collagen I was examined by Western-blot. RESULTS The ROB proliferation was inhibited by icariin in a dose-dependent manner. But it evidently led to osteogenic process and maturation. 1 x 10(-5) mol/L was the best concentration. Icariin improved the secretion of collagen I, CFU-F(ALP) amounts and mineralized nodules significantly. It also enhanced the mRNA level of Runx-2 and Osterix. CONCLUSIONS The icariin with final concentration of 1 x 10(-5) mol/L can enhance the osteogenic differentiation and maturation of ROB significantly, suggesting that icariin has the activity of inducing bone formation, it has the potential to be developed into a new drug of anti-osteoporosis.

UI MeSH Term Description Entries
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D002113 Calcification, Physiologic Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. Bone Mineralization,Calcification, Physiological,Physiologic Calcification,Mineralization, Bone,Physiological Calcification
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
September 1997, Zhonghua fu chan ke za zhi,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
May 2015, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
March 2002, Journal of biomedical materials research,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
February 2012, Shanghai kou qiang yi xue = Shanghai journal of stomatology,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
June 2014, Chinese journal of natural medicines,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
October 2007, Die Pharmazie,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
November 2002, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
January 2015, International journal of clinical and experimental medicine,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
July 2014, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Yuan-kun Zhai, and Zhi-zhong Li, and Ke-ming Chen, and Na Zhang, and Guo-zheng Cheng, and Rui-qing Zhu
April 1998, Cell and tissue research,
Copied contents to your clipboard!